These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11990903)

  • 21. Quetiapine and QTc issues: a case report.
    Gupta S; Nienhaus K; Shah SA
    J Clin Psychiatry; 2003 May; 64(5):612-3. PubMed ID: 12755671
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of the CSM advice on thioridazine on general practitioner prescribing behaviour in Leeds: time series analysis.
    Wright NM; Roberts AJ; Allgar VL; Tompkins CN; Greenwood DC; Laurence G
    Br J Gen Pract; 2004 May; 54(502):370-3. PubMed ID: 15113522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic use in a patient with a prolonged QTc interval.
    Winter EC; Alessi LE
    Psychosomatics; 2008; 49(3):272-3. PubMed ID: 18448786
    [No Abstract]   [Full Text] [Related]  

  • 24. QTc prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment.
    Grande I; Pons A; Baeza I; Torras Á; Bernardo M
    Hum Psychopharmacol; 2011 Aug; 26(6):397-403. PubMed ID: 21826738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Repercussions of the withdrawal of thioridazine].
    Buj Alvarez I; Pifarré Paredero J; Idini E; Puigdevall Ruestes M
    Actas Esp Psiquiatr; 2008; 36(3):183-6. PubMed ID: 18478459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis.
    Naguy A; Al-Khadhari S; Pridmore S
    Psychopharmacol Bull; 2022 Jun; 52(3):68-71. PubMed ID: 35815172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Seeing a new classification of active medications in psychoses].
    Costentin J
    Encephale; 2007 Oct; 33(5):721-2. PubMed ID: 18357841
    [No Abstract]   [Full Text] [Related]  

  • 28. QTc prolongation, torsades de pointes, and psychotropic medications.
    Beach SR; Celano CM; Noseworthy PA; Januzzi JL; Huffman JC
    Psychosomatics; 2013; 54(1):1-13. PubMed ID: 23295003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QTc interval lengthening and debrisoquine metabolic ratio in psychiatric patients treated with oral haloperidol monotherapy.
    LLerena A; Berecz R; de la Rubia A; Dorado P
    Eur J Clin Pharmacol; 2002 Jun; 58(3):223-24. PubMed ID: 12162273
    [No Abstract]   [Full Text] [Related]  

  • 30. Antipsychotic drug prescribing in the elderly is cause for concern.
    Percudani M; Barbui C; Fortino I; Petrovich L
    Int Clin Psychopharmacol; 2004 Nov; 19(6):347-50. PubMed ID: 15486521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuation of antipsychotic-induced hyperprolactinemia with clozapine.
    Bunker MT; Marken PA; Schneiderhan ME; Ruehter VL
    J Child Adolesc Psychopharmacol; 1997; 7(1):65-9. PubMed ID: 9192542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QTc interval in patients with schizophrenia receiving antipsychotic treatment as monotherapy or polypharmacy.
    Elliott A; Mørk TJ; Højlund M; Christensen T; Jeppesen R; Madsen N; Viuff AG; Hjorth P; Nielsen JC; Munk-Jørgensen P
    CNS Spectr; 2018 Aug; 23(4):278-283. PubMed ID: 28659221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
    Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
    Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrected QT Interval Prolongation in Psychopharmacological Treatment and Its Modulation by Genetic Variation.
    Corponi F; Fabbri C; Boriani G; Diemberger I; Albani D; Forloni G; Serretti A
    Neuropsychobiology; 2019; 77(2):67-72. PubMed ID: 30544110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients].
    Gallien M; Schnetzler JP; Morin J
    Ann Med Psychol (Paris); 1975 Feb; 1(2):237-48. PubMed ID: 9021
    [No Abstract]   [Full Text] [Related]  

  • 36. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
    Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
    J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QT and QTc in Male Patients with Psychotic Disorders Treated with Atypical Neuroleptics.
    Miniati M; Simoncini M; Vanelli F; Franceschini C; Massimetti G; Carmassi C; Dell'Osso L
    ScientificWorldJournal; 2017; 2017():1951628. PubMed ID: 28785719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole.
    Lindström E; Farde L; Eberhard J; Haverkamp W
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):615-29. PubMed ID: 15963244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antipsychotic agents and the heart].
    Huttunen MO
    Duodecim; 2002; 118(15):1579. PubMed ID: 12244632
    [No Abstract]   [Full Text] [Related]  

  • 40. QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.
    Xiang YT; Chiu HF; Ungvari GS; Correll CU; Lai KY; Wang CY; Si TM; Lee EH; He YL; Yang SY; Chong MY; Kua EH; Fujii S; Sim K; Yong MK; Trivedi JK; Chung EK; Udomratn P; Chee KY; Sartorius N; Tan CH; Shinfuku N
    Hum Psychopharmacol; 2015 Mar; 30(2):94-9. PubMed ID: 25611192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.